GlassScriptPhysician profile
Adam S Footer
NPI 1891011680
$1,261.52
in general payments reported to CMS, 2019-2025
21 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2021: $41.78 · 2022: $263 · 2023: $402 · 2024: $187 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $447.47 | 2019-2024 | |
| Astellas Pharma US INC | $176.42 | 2023-2025 | Veozah |
| Allergan, INC. | $72.27 | 2019 | |
| Sage Therapeutics, LLC | $70.84 | 2023-2024 | |
| Pfizer INC. | $70.45 | 2022-2023 | |
| Therapeuticsmd, INC. | $64.00 | 2019-2022 | |
| Millicent US INC | $52.94 | 2023-2025 | Femlyv, Intrarosa, Femring |
| Avion Pharmaceuticals | $46.97 | 2019-2022 | |
| Hologic Sales and Service, LLC | $39.52 | 2019-2021 | |
| Aspira Women'S Health INC | $26.57 | 2023 | Ova1 |
| Lupin INC. | $24.58 | 2019 | |
| Becton, Dickinson and Company | $22.28 | 2024 | Bd Max System, Bd Max Instrument |
| Sumitomo Pharma America, INC. | $21.52 | 2024 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $20.84 | 2019 | |
| Coopersurgical, INC. | $20.41 | 2024 | Paragard T 380a |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.27 | 2024 | Evenity, Prolia |
| Daiichi Sankyo INC. | $18.68 | 2022 | |
| Vertical Pharmaceuticals, LLC | $17.12 | 2019 | |
| Tms Neurohealth Centers INC. | $12.13 | 2025 | Tms Neurohealth Centers INC. |
| Sanofi Pasteur INC. | $11.64 | 2019 | |
| Organon LLC | $5.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Footer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.